BRIEF published on 02/16/2026 at 17:55, 8 months 22 days ago Aramis Group Discloses Share Buybacks in February 2026 Euronext Paris Share Buyback Aramis Group February 2026 Online Used Car Sales
BRIEF published on 02/16/2026 at 17:55, 8 months 22 days ago Le groupe Aramis annonce des rachats d'actions en février 2026 Rachat D'actions Euronext Paris Groupe Aramis Février 2026 Vente De Voitures D'occasion En Ligne
BRIEF published on 02/16/2026 at 17:51, 8 months 22 days ago HBM Healthcare Reports February 2026 Financial Performance Financial Figures Share Price NAV HBM Healthcare February 2026
BRIEF published on 02/16/2026 at 17:51, 8 months 22 days ago HBM Healthcare publie ses résultats financiers de février 2026 NAV Données Financières Prix De L'action HBM Healthcare Février 2026
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago FIGEAC AÉRO Renforce son Partenariat sur le Moteur M88 du Rafale FIGEAC AÉRO Moteur M88 Safran Engines Programme Rafale Production France
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago FIGEAC AÉRO Secures New Agreement for Rafale Engine Component Business Growth FIGEAC AÉRO Aerospace Manufacturing Safran Partnership Rafale Engine
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago FIGEAC AÉRO Strengthens its Partnership on the Rafale M88 Engine FIGEAC AÉRO M88 Engine Safran Engines Rafale Program Produced In France
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago FIGEAC AÉRO conclut un nouvel accord pour un composant moteur du Rafale Croissance De L'entreprise FIGEAC AÉRO Fabrication Aérospatiale Partenariat Safran Moteur Rafale
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago Newron Pharmaceuticals Secures EUR 38 Million for Phase III Evenamide Program Financing Newron Pharmaceuticals Evenamide Phase III Trials Treatment-resistant Schizophrenia
BRIEF published on 02/16/2026 at 17:50, 8 months 22 days ago Newron Pharmaceuticals obtient 38 millions d'euros pour son programme de phase III sur l'événamide. Financement Newron Pharmaceuticals Evenamide Essais De Phase III Schizophrénie Résistante Au Traitement
Published on 11/11/2026 at 03:30, 6 hours 32 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 9 hours 22 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 10 hours 32 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 11 hours 2 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 11 hours 2 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 09:40, 21 minutes ago Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 11/11/2026 at 09:25, 37 minutes ago DOBOT Unveils Three New Products at Its 2026 Robotics Ecosystem Conference
Published on 11/11/2026 at 09:05, 57 minutes ago DeepL unveils Aure, its most lifelike Voice AI translation model yet
Published on 11/11/2026 at 09:00, 1 hour 2 minutes ago Municipality Finance issues a USD 50 million tap under its MTN programme
Published on 11/10/2026 at 18:00, 16 hours 2 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 16 hours 17 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 16 hours 27 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 16 hours 30 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
